(Q46745193)

English

Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

0 references

multicenter clinical trial

1 reference

based on heuristic

inferred from title

multiple myeloma

1 reference

based on heuristic

inferred from title

Koussay Dellagi

20

object named as

Koussay Dellagi

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

author name string

Abderrahman Abdelkefi

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

Saloua Ladeb

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

Lamia Torjman

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

Tarek Ben Othman

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

Amel Lakhal

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

Neila Ben Romdhane

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

Halima El Omri

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

Moez Elloumi

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

Hatem Belaaj

9

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

Ramzi Jeddi

10

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

Lamia Aissaouï

11

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

Habib Ksouri

12

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

Assia Ben Hassen

13

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

Fahmi Msadek

14

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

Ali Saad

15

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

Mohamed Hsaïri

16

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

Kamel Boukef

17

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

Ahlem Amouri

18

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

Hechmi Louzir

19

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

Abdeladhim Ben Abdeladhim

21

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

Tunisian Multiple Myeloma Study Group

22

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

language of work or name

0 references

publication date

17 September 2007

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

111

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

1805-1810

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: results of an open-label multicenter phase 2 study of efficacy, toxicity, and biological activity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Does maintenance therapy with thalidomide benefit patients with multiple myeloma?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Benefit and timing of second transplantations in multiple myeloma: clinical findings and methodological limitations in a European Group for Blood and Marrow Transplantation registry study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myeloma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Prolonged overall survival with second on-demand autologous transplant in multiple myeloma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

New drugs for myeloma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Salvage autologous or allogeneic transplantation for multiple myeloma refractory to or relapsing after a first-line autograft?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Single versus double autologous stem-cell transplantation for multiple myeloma.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

International uniform response criteria for multiple myeloma.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Thalidomide alone or with dexamethasone for previously untreated multiple myeloma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

First-line thalidomide-dexamethasone therapy in preparation for autologous stem cell transplantation in young patients (<61 years) with symptomatic multiple myeloma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Diagnosis and management of multiple myeloma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Antitumor activity of thalidomide in refractory multiple myeloma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Thalidomide and thrombosis. A meta-analysis.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Maintenance therapy with thalidomide improves survival in patients with multiple myeloma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Development of neuropathy in patients with myeloma treated with thalidomide: patterns of occurrence and the role of electrophysiologic monitoring

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Thalidomide and hematopoietic-cell transplantation for multiple myeloma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Consolidation therapy of multiple myeloma with thalidomide-dexamethasone after intensive chemotherapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2007-07-101212

Identifiers

10.1182/BLOOD-2007-07-101212

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/17875806

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46745193&oldid=2129595594"